BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 17890953)

  • 21. Activation of the fibrinolytic system in patients with fulminant liver failure.
    Pernambuco JR; Langley PG; Hughes RD; Izumi S; Williams R
    Hepatology; 1993 Dec; 18(6):1350-6. PubMed ID: 8244260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Studies on the mechanism of hyperfibrinolysis in liver cirrhosis--changes of plasma t-PA, PAI-1 and active PAI-1 levels in liver cirrhosis].
    Matsuura R; Soma M; Maeda Y; Kasakura S
    Rinsho Byori; 1995 Dec; 43(12):1256-60. PubMed ID: 8569037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma tetranectin levels and disease activity in patients with rheumatoid arthritis.
    Kamper EF; Kopeikina LT; Koutsoukos V; Stavridis J
    J Rheumatol; 1997 Feb; 24(2):262-8. PubMed ID: 9034981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma levels and urinary excretion of fibrinolytic and protease inhibitory proteins in nephrotic syndrome.
    Vaziri ND; Gonzales EC; Shayestehfar B; Barton CH
    J Lab Clin Med; 1994 Jul; 124(1):118-24. PubMed ID: 7518491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased levels of PAI-1 and alpha 2-antiplasmin contribute to enhanced fibrinolytic activity in divers.
    Radziwon P; Olszański R; Tomaszewski R; Lipska A; Dabrowiecki Z; Korzeniewski K; Siermontowski P; Boczkowska-Radziwon B
    Thromb Res; 2007; 121(2):235-40. PubMed ID: 17521709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The kinetics of plasmin inhibition by aprotinin in vivo.
    Kang HM; Kalnoski MH; Frederick M; Chandler WL
    Thromb Res; 2005; 115(4):327-40. PubMed ID: 15668193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coagulation and fibrinolytic activity in patients with acute cerebral infarction.
    Li F; Zhang G; Zhao W
    Chin Med J (Engl); 2003 Mar; 116(3):475-7. PubMed ID: 12781064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic coagulation and fibrinolysis in patients with or at risk for the adult respiratory distress syndrome.
    Groeneveld AB; Kindt I; Raijmakers PG; Hack CE; Thijs LG
    Thromb Haemost; 1997 Dec; 78(6):1444-9. PubMed ID: 9423792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated tissue plasminogen activator and reduced plasminogen activator inhibitor promote hyperfibrinolysis in trauma patients.
    Cardenas JC; Matijevic N; Baer LA; Holcomb JB; Cotton BA; Wade CE
    Shock; 2014 Jun; 41(6):514-21. PubMed ID: 24667610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma fibrinolytic activators and their inhibitors in women suffering from early recurrent abortion of unknown etiology.
    Gris JC; Neveu S; Mares P; Biron C; Hedon B; Schved JF
    J Lab Clin Med; 1993 Nov; 122(5):606-15. PubMed ID: 8228580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of direct percutaneous transluminal coronary angioplasty treatment of acute myocardial infarction on plasma levels of haemostatic and fibrinolytic factors.
    Saito M; Nakabayashi T; Iuchi K; Ishikawa T; Kaseno K; Yoshida T; Asakura H; Matsuda T
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):801-4. PubMed ID: 7507363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selected parameters of fibrinolysis system in patients with dermatitis herpetiformis.
    Wankiewicz A; Iwan-Zietek I; Kotschy M; Gwieździński Z
    Med Sci Monit; 2002 Mar; 8(3):CR189-92. PubMed ID: 11887034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sex differences in the determinants of fibrinolytic activity.
    MacCallum PK; Cooper JA; Howarth DJ; Meade TW; Miller GJ
    Thromb Haemost; 1998 Mar; 79(3):587-90. PubMed ID: 9531046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dyslipidemias and fibrinolysis.
    Puccetti L; Bruni F; Pasqui AL; Pastorelli M; Bova G; Cercignani M; Palazzuoli A; Auteri A
    Ital Heart J; 2002 Oct; 3(10):579-86. PubMed ID: 12478815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxidative stress effects fibrinolytic system in dialysis uraemic patients.
    Pawlak K; Pawlak D; Mysliwiec M
    Thromb Res; 2006; 117(5):517-22. PubMed ID: 15964061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Study of fibrinolysis inhibitors in 117 acute leukemia patients].
    Wang W; Ji CY; Ye JJ; Zhu YY; Guo DM; Ji M
    Zhonghua Xue Ye Xue Za Zhi; 2008 Mar; 29(3):183-6. PubMed ID: 18788619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Do plasma biomarkers of coagulation and fibrinolysis differ between patients who have experienced an acute myocardial infarction versus stable exertional angina?
    Itakura H; Sobel BE; Boothroyd D; Leung LL; Iribarren C; Go AS; Fortmann SP; Quertermous T; Hlatky MA;
    Am Heart J; 2007 Dec; 154(6):1059-64. PubMed ID: 18035075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Fluctuations of tissue-type plasminogen activator.plasminogen activator inhibitor-1 complex in patients with DIC].
    Nagaizumi K; Kuroso K; Amano K; Sato T; Fukutake K; Fujimaki M
    Rinsho Byori; 1994 Jul; 42(7):707-12. PubMed ID: 8065036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Post-traumatic plasminogenesis in intraarticular exudate in the knee joint.
    Rość D; Powierza W; Zastawna E; Drewniak W; Michalski A; Kotschy M
    Med Sci Monit; 2002 May; 8(5):CR371-8. PubMed ID: 12011780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet (dys)function and plasma plasminogen levels in hemodialysis patients.
    Salobir B; Sabovic M; Zupan IP; Ponikvar JB
    Ther Apher Dial; 2008 Apr; 12(2):133-6. PubMed ID: 18387161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.